Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjun Song

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
Biorxiv : the Preprint Server for Biology|August 19, 2022
A replicon RNA vaccine induces durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have wanedMegan A Oâ Connor, David W Hawman, Kimberly Meade-White, et al.
Cell Reports|December 15, 2021
IFP35 as a promising biomarker and therapeutic target for the syndromes induced by SARS-CoV-2 or influenza virusYang Yu, Na Xu, Qi Cheng, et al.
Investigative Ophthalmology & Visual Science|May 26, 2026
Evaluation of Vascular Biomarkers in Diabetic Retinopathy Using Ultrawide-Field Swept-Source Optical Coherence Tomography Angiography: The DRIVE StudyWei Hing Seah, Wenjun Song, Lingyi Zhuang, et al.
Ophthalmology Science|February 18, 2026
Automated Nonperfusion Quantification in Diabetic Retinopathy on Ultra-Widefield Swept-Source OCT AngiographyTai Yong Loh, Juling Sia, Wei Hing Seah, et al.
Nature Communications|July 3, 2024
A(H2N2) and A(H3N2) influenza pandemics elicited durable cross-reactive and protective antibodies against avian N2 neuraminidasesZaolan Liang, Xia Lin, Lihong Sun, et al.
Emerging Microbes & Infections|May 4, 2026
Enhanced Immunogenicity and Dose-Sparing Efficacy of SelfAmplifying RNA Vaccines Against Seasonal Influenza Across SubtypesMengting Huang, Yun Quan, Ruyi Chen, et al.
Plos Pathogens|April 19, 2023
A replicon RNA vaccine can induce durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have wanedMegan A O'Connor, David W Hawman, Kimberly Meade-White, et al.
Lancet (London, England)|April 30, 2013
Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genomeYu Chen, Weifeng Liang, Shigui Yang, et al.
Plos Pathogens|July 6, 2021
Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacyFredrik Barrenäs, Scott G Hansen, Lynn Law, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Biorxiv : the Preprint Server for Biology|August 19, 2022
A replicon RNA vaccine induces durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have wanedMegan A Oâ Connor, David W Hawman, Kimberly Meade-White, et al.
Cell Reports|December 15, 2021
IFP35 as a promising biomarker and therapeutic target for the syndromes induced by SARS-CoV-2 or influenza virusYang Yu, Na Xu, Qi Cheng, et al.
Investigative Ophthalmology & Visual Science|May 26, 2026
Evaluation of Vascular Biomarkers in Diabetic Retinopathy Using Ultrawide-Field Swept-Source Optical Coherence Tomography Angiography: The DRIVE StudyWei Hing Seah, Wenjun Song, Lingyi Zhuang, et al.
Ophthalmology Science|February 18, 2026
Automated Nonperfusion Quantification in Diabetic Retinopathy on Ultra-Widefield Swept-Source OCT AngiographyTai Yong Loh, Juling Sia, Wei Hing Seah, et al.
Nature Communications|July 3, 2024
A(H2N2) and A(H3N2) influenza pandemics elicited durable cross-reactive and protective antibodies against avian N2 neuraminidasesZaolan Liang, Xia Lin, Lihong Sun, et al.
Emerging Microbes & Infections|May 4, 2026
Enhanced Immunogenicity and Dose-Sparing Efficacy of SelfAmplifying RNA Vaccines Against Seasonal Influenza Across SubtypesMengting Huang, Yun Quan, Ruyi Chen, et al.
Plos Pathogens|April 19, 2023
A replicon RNA vaccine can induce durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have wanedMegan A O'Connor, David W Hawman, Kimberly Meade-White, et al.
Lancet (London, England)|April 30, 2013
Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genomeYu Chen, Weifeng Liang, Shigui Yang, et al.
Plos Pathogens|July 6, 2021
Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacyFredrik Barrenäs, Scott G Hansen, Lynn Law, et al.
Pageof 12